| Application no. and date | 07862580.3 (espacenet) (Federated) (European Patent Register), 20071205 | | Patent/reg. no. and date | DK/EP 2096919, 20160302 | | Publication date | 20090909 | | Priority no. and date | US 873090 P, 20061205 | | EP pub. no. and date |
EP 2096919 20090909 | | Effective date | | | Applicant/owner | Bayer Intellectual Property GmbH, Alfred-Nobel-Str. 50
40789 Monheim am Rhein, DE | | Applicant ref. no. | BBS MSW5279PCT-EP | | Inventor | CAMPBELL, Ann-Marie, 69 Lynn Drive
Monroe, CT 06468, US,
MICHELS, Martin, Hoffnungsthaler Str. 9
51109 Koln, DE,
ROWLEY, R. Bruce, 1102 Gallop Circle
New Hope, Pennsylvania 18938, US,
REDMAN, Aniko, 1001 Gordonview Court
Durham, North Carolina 27713, US,
WOOD, Jill, 3007 Ridge Road
North Haven
CT 06473, US,
SCOTT, William, 10 Oakside Lane
Peekswill
NY 10566-2546, US,
HENTEMANN, Martin, 29 Brinham Rd
Carlisle
MA 01741, US,
BULLION, Ann-Marie, 200 Ross Raod apt L2
King of Prussia
PA 19406, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 31/5377 (2006.01) , C07D 487/04 (2006.01) | | Title | SUBSTITUEREDE 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINDERIVATER, DER ER ANVENDELIGE TIL BEHANDLING AF HYPERPROLIFERATIVE FORSTYRRELSER OG SYGDOMME, DER ER FORBUNDET MED ANGIOGENESE | | Int. application no. | US2007024985 | | Int. publication no. | WO2008070150 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
